161 related articles for article (PubMed ID: 30115537)
1. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
2. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
Yong L; YuFeng Z; Guang B
Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
[TBL] [Abstract][Full Text] [Related]
3. TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling.
Gu Y; Wang Q; Guo K; Qin W; Liao W; Wang S; Ding Y; Lin J
J Pathol; 2016 May; 239(1):60-71. PubMed ID: 27071482
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
5. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
[TBL] [Abstract][Full Text] [Related]
6. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
7. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
8. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
9. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
10. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
11. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
Yu MH; Luo Y; Qin SL; Zhong M
Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
[TBL] [Abstract][Full Text] [Related]
13. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of IRF-2 expression in colorectal cancer.
Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
[TBL] [Abstract][Full Text] [Related]
15. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
17. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
18. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
Fan X; Zhang X; Shen J; Zhao H; Yu X; Chen Y; Zhuang Z; Deng X; Feng H; Wang Y; Peng L
PLoS One; 2016; 11(2):e0149028. PubMed ID: 26871953
[TBL] [Abstract][Full Text] [Related]
19. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
